能動免疫と受動免疫

Active immunity develops when an individual's immune system is stimulated to produce a protective response to a pathogen, typically activating both B cells and T cells. This occurs naturally through infection or artificially through vaccination with dead or weakened pathogens. The body produces antibodies to combat future infections with the same pathogen, providing long-term protection through immunological memory.

Natural active immunity is acquired through infection and recovery from disease, enabling the body to recognize and fight the pathogen more effectively upon future exposure. Artificial active immunity is obtained through vaccines containing killed or weakened pathogens or their components. Both develop immunological memory, but vaccines provide protection without experiencing acute infection.

Passive immunity results from transmitting preformed antibodies directly into an individual without requiring them to generate their own immune response. Protection occurs immediately but is temporary, lasting only until the antibodies naturally degrade. Unlike active immunity, passive immunity does not develop immunological memory, so the body cannot mount a faster response upon future pathogen exposure.

Naturally acquired passive immunity occurs when IgG antibodies transfer from mother to fetus through the placenta, protecting the fetus and newborn during initial months. Newborns also receive IgA antibodies from breast milk, benefiting from the mother's immunological memory against pathogens she has encountered. This maternal protection is temporary and diminishes as antibodies degrade.

Artificially acquired passive immunity typically involves immunoglobulin injections derived from humans or animals previously exposed to specific pathogens. This treatment provides quick temporary protection for individuals exposed to dangerous pathogens or toxins. It is used to treat conditions like hepatitis A, rabies, tetanus, botulism, and venomous snake bites.

Vaccines stimulate the body to produce antibodies and develop immunological memory without causing acute infection. This breakthrough enabled eradication of smallpox and control of numerous infectious diseases including polio, measles, and pertussis. More recently, vaccines have played a crucial role in mitigating the impact of COVID-19 by preparing the immune system for pathogen recognition.

The primary limitation of passive immunity is the absence of immunological memory development. After antibody transfer, protection is only temporary and lasts until the antibodies degrade. In contrast, active immunity generates long-term protection because the body retains the ability to rapidly recognize and respond to future encounters with the same pathogen.